Strides Arcolab unit's Milan-based factory gets FDA OK

09/19/2013 | BioSpectrum Asia

The FDA has approved the drug facility of Strides Arcolab's Italian unit Beltapharm in Milan, allowing the company to enter the U.S. semisolid market. The facility will produce creams, ointments, semisolids and liquids, the drugmaker said in a statement. The facility is already cleared in Australia and the European Union.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN